Veritas Aortic Solutions
Veritas Aortic Solutions is developing the Veritas Transcatheter Valved Aortic Root Conduit (TVARC), a unified endovascular platform designed to treat complex conditions affecting the aortic root, coronary arteries, and ascending aorta. The technology aims to replace highly invasive open surgical procedures with a minimally invasive approach that addresses coronary perfusion and aortic root reconstruction challenges.
- Medical Devices
- Healthcare Technology
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
Treatment of the ascending aorta and aortic root still relies predominantly on highly invasive open surgical procedures, despite decades of progress in structural heart intervention. These technically demanding operations pose significant risks, especially for critically ill patients with complex aortic disease.
Solution
Veritas Aortic Solutions is advancing a new category of transcatheter therapy for complex aortic disease through its Veritas Transcatheter Valved Aortic Root Conduit (TVARC) platform. The technology is designed to address longstanding procedural challenges surrounding coronary perfusion, aortic root reconstruction, and ascending aortic repair through a unified endovascular approach. By reimagining how these critical structures can be treated via a minimally invasive route, Veritas aims to simplify treatment, reduce invasiveness, and expand therapeutic possibilities for patients facing life-threatening conditions.
Target Audience
Primary beneficiaries are patients with complex aortic disease affecting the aortic root, coronary arteries, and ascending aorta, as well as the interventional cardiologists and cardiothoracic surgeons who treat them.
Features
- TVARC is a transcatheter valved aortic root conduit that integrates aortic root, coronary artery, and ascending aorta treatment into a single endovascular platform
- Purpose-built to address procedural challenges around coronary perfusion and aortic root reconstruction
- Designed for unified endovascular repair of the heart's most critical vascular structures, replacing the need for open surgical access
- Developed in collaboration with leading physicians and engineers to enable greater precision and confidence in treating critically ill patients